NB PHARMA
ActiveSummary
NB PHARMA has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €573,958 and a net result of €56,725. Equity is growing by about 67% per year across the filed financial years. Its solvency ranks better than 87% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 10-08-2023
Read from the deeds: 1 provision, deed of 10-08-2023